Multi-centre Study to Evaluate ACAF Versus Laminoplasty in Treating Cervical Ossification of the Posterior Longitudinal Ligament

NCT ID: NCT04968028

Last Updated: 2024-04-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-17

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the efficacy, safety and imaging outcomes between Anterior Controllable Antedisplacement and Fusion (ACAF) and Laminoplasty in the treatment of severe ossification of cervical posterior longitudinal ligament.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a national, multicenter, prospective, randomized controlled trial to compare the safety and efficacy of ACAF and posterior laminoplasty in the treatment of severe ossification of cervical posterior longitudinal ligament. In this study, 164 adult patients aged 18-70 with severe copll were randomly assigned to the experimental group (using ACAF) and the control group (using lamp) according to the ratio of 1:1. The patients were followed up for 2 years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ossification of Posterior Longitudinal Ligament Cervical Spondylosis With Myelopathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

In view of the obvious differences between the two surgery methods, this study was designed as an open-label trial. However, the results of X-ray, computed tomography (CT) and magnetic resonance imaging (MRI) will be independently reviewed by an independent radiographic review committee in a blind fashion in addition to the evaluation by site investigators.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ACAF

Participants underwent anterior decompression of Anterior Controllable Antedisplacement and Fusion

Group Type EXPERIMENTAL

ACAF

Intervention Type PROCEDURE

(1)A standard right-side Smith-Robinson approach is performed. (2) The involved disc tissues are removed. The posterior longitudinal ligament is cut down at the levels cephalic and caudal to OPLL. (3) The anterior portion of the middle vertebral bodies is removed according to the thickness of ossification. Suitable cages are placed into each intervertebral space. (4) On the left side of the vertebra, a 2-mm-wide groove is created at the medial border of the transverse foramina. After that, an curved plated is fixed with screws. (5) On the right side of the vertebrae, a similar groove was also created. (6) Finally, tightening the screws to achieve a gradual evaluation of the vertebrae with OPLL.

Laminoplasty

Participants underwent posterior decompression of Laminoplasty

Group Type EXPERIMENTAL

Laminoplasty

Intervention Type PROCEDURE

(1) In the prone position, the skin and nuchal ligament were cut through the posterior median incision, and the paravertebral muscles were stripped layer by layer to expose the bilateral vertebral lamina, lateral mass and articular process.(2) Part of spinous process were removed with bone biting forceps. The side with more severe symptoms was selected as the open side, bone groove was performed at 2-3 mm of the medial edge of bilateral facet joints with the medial cortex was reserved at the shaft side.(3) Slowly lift the lamina and maintained.(4)Determining the opening width of each segment by trial, and selecting the appropriate size Arch miniplate, and fixed with screws.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ACAF

(1)A standard right-side Smith-Robinson approach is performed. (2) The involved disc tissues are removed. The posterior longitudinal ligament is cut down at the levels cephalic and caudal to OPLL. (3) The anterior portion of the middle vertebral bodies is removed according to the thickness of ossification. Suitable cages are placed into each intervertebral space. (4) On the left side of the vertebra, a 2-mm-wide groove is created at the medial border of the transverse foramina. After that, an curved plated is fixed with screws. (5) On the right side of the vertebrae, a similar groove was also created. (6) Finally, tightening the screws to achieve a gradual evaluation of the vertebrae with OPLL.

Intervention Type PROCEDURE

Laminoplasty

(1) In the prone position, the skin and nuchal ligament were cut through the posterior median incision, and the paravertebral muscles were stripped layer by layer to expose the bilateral vertebral lamina, lateral mass and articular process.(2) Part of spinous process were removed with bone biting forceps. The side with more severe symptoms was selected as the open side, bone groove was performed at 2-3 mm of the medial edge of bilateral facet joints with the medial cortex was reserved at the shaft side.(3) Slowly lift the lamina and maintained.(4)Determining the opening width of each segment by trial, and selecting the appropriate size Arch miniplate, and fixed with screws.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Anterior Controllable Antedisplacement and Fusion

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The patient's age is 18-70 years old, regardless of gender;
2. The patient was diagnosed as severe ossification of the posterior longitudinal ligament (X-ray or CT showed ossification of the posterior longitudinal ligament); The imaging findings showed occupied ratio ≥ 60% or involved three or more segments;
3. Symptoms of spinal cord and nerve root compression, or accompanied by spinal cord compression symptoms such as dysfunction of urination and defecation, conservative treatment was ineffective or aggravated gradually;
4. The participant (or his legal guardian) can sign the informed consent.

Exclusion Criteria

1. Congenital malformations (including but not limited to occipitocervical malformations, congenital cervical fusion, cervical related neurovascular malformations), ossification of cervical ligamentum flavum, cervical trauma, cervical cancer, cervical tuberculosis and other inflammatory diseases;
2. Patients with other spinal diseases such as thoracolumbar vertebrae that affect clinical symptoms; Patients with motor neuron diseases such as amyotrophic lateral sclerosis and other nervous system diseases;
3. The symptoms were aggravated due to recent trauma;
4. Patients who participated in other clinical trials in recent 3 months;
5. The participant (or his legal guardian) with mental illness and cognitive impairment can not give full informed consent;
6. Those who are in poor health and can not tolerate surgery; The patients were not suitable for surgical treatment after preoperative examination.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Changhai Hospital

OTHER

Sponsor Role collaborator

Shanghai 6th People's Hospital

OTHER

Sponsor Role collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

Sponsor Role collaborator

Tongji Hospital

OTHER

Sponsor Role collaborator

Peking University Shenzhen Hospital

OTHER

Sponsor Role collaborator

The Second Affiliated Hospital of Harbin Medical University

OTHER

Sponsor Role collaborator

Xuanwu Hospital, Beijing

OTHER

Sponsor Role collaborator

Jining Medical University

OTHER

Sponsor Role collaborator

The Affiliated Hospital of Qingdao University

OTHER

Sponsor Role collaborator

Shanxi Bethune Hospital

OTHER

Sponsor Role collaborator

Tang-Du Hospital

OTHER

Sponsor Role collaborator

Shanghai Changzheng Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jiangang Shi, Doctor

Role: STUDY_CHAIR

Shanghai Changzheng Hospital

Dan Han, Master

Role: STUDY_DIRECTOR

Shanghai Changzheng Hospital

Yu Chen, Doctor

Role: PRINCIPAL_INVESTIGATOR

Shanghai Changzheng Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking University Shenzhen Hospital

Shenzhen, Guangdong, China

Site Status RECRUITING

The 2nd Affiliated Hospital of Harbin Medical University

Harbin, Heilongjaing, China

Site Status NOT_YET_RECRUITING

Xuanwu Hospital Capital Medical University

Beijing, Pekin, China

Site Status RECRUITING

Affiliated Hospital of Jining Medical University

Jining, Shandong, China

Site Status RECRUITING

The Affiliated Hospital of Qingdao University

Qingdao, Shandong, China

Site Status RECRUITING

Shanghai Changzheng Hospital

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai Sixth People's Hospital

Shanghai, Shanghai Municipality, China

Site Status NOT_YET_RECRUITING

The First Affiliated Hospital of Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai Tongji Hospital, School of Medicine, Tongji University

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai Changhai Hospital

Shanghai, Shanghai Municipality, China

Site Status NOT_YET_RECRUITING

Shanxi Bethune Hospital

Taiyuan, Shanxi, China

Site Status RECRUITING

The Second Affiliated Hospital, Air Force Medical University

Xi’an, Shanxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dan Han, Master

Role: CONTACT

+86 18317028536

Yu Chen, Doctor

Role: CONTACT

+86 13916821845

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Binsheng Yu, Doctor

Role: primary

+86 13682570903

Yan Shi, Master

Role: backup

+86 13424384282

Jinglong Yan, Doctor

Role: primary

+86 13069715632

Ye Ji, Doctor

Role: backup

+86 13633634078

Zan Chen, Doctor

Role: primary

+86 13911712120

Wanru Duan, Doctor

Role: backup

+86 13581803400

Weihong Zhang, Doctor

Role: primary

+86 15054796099

Yanming Li, Doctor

Role: backup

+86 15866067775

Yongming Xi, Doctor

Role: primary

+86 18661807802

Jiale Shao, Doctor

Role: backup

+86 18661806662

Jiangang Shi, Doctor

Role: primary

+86 13701668346

Dan Han, Master

Role: backup

+86 18317028536

Jianguang Xu, Doctor

Role: primary

+86 13701698475

Guowang Zhang, Doctor

Role: backup

+86 18501765462

Qiang Shen, Doctor

Role: primary

+86 13671877906

Liang Zhu, Doctor

Role: backup

+86 13818236846

Bin Ma, Doctor

Role: primary

+86 13564678952

Ning Xie, Doctor

Role: backup

+86 13601981863

Ming Li, Doctor

Role: primary

+86 13801681322

Xiaoyi Zhou, Doctor

Role: backup

+86 13818909826

Haoyu Feng, Doctor

Role: primary

+86 13903468578

Lin Sun, Doctor

Role: backup

+86 13593148640

Bo Liao, Doctor

Role: primary

+86 13909256861

Xiaoxiang Li, Doctor

Role: backup

+86 15929779234

References

Explore related publications, articles, or registry entries linked to this study.

Chen Y, Sun J, Yuan X, Guo Y, Yang H, Chen D, Shi J. Comparison of Anterior Controllable Antedisplacement and Fusion With Posterior Laminoplasty in the Treatment of Multilevel Cervical Ossification of the Posterior Longitudinal Ligament: A Prospective, Randomized, and Control Study With at Least 1-Year Follow Up. Spine (Phila Pa 1976). 2020 Aug 15;45(16):1091-1101. doi: 10.1097/BRS.0000000000003462.

Reference Type BACKGROUND
PMID: 32097261 (View on PubMed)

Sun K, Wang S, Huan L, Sun J, Xu X, Sun X, Shi J, Guo Y. Analysis of the spinal cord angle for severe cervical ossification of the posterior longitudinal ligament: comparison between anterior controllable antedisplacement and fusion (ACAF) and posterior laminectomy. Eur Spine J. 2020 May;29(5):1001-1012. doi: 10.1007/s00586-019-06216-6. Epub 2019 Dec 3.

Reference Type BACKGROUND
PMID: 31797138 (View on PubMed)

Chen Y, Sun J, Han D, Yuan X, Wang Y, Guo Y, Zhong X, Shi J. An open-label randomized multi-Centre study to evaluate anterior controllable Antedisplacement and fusion versus posterior Laminoplasty in patients with cervical ossification of the posterior longitudinal ligament: study design and analysis plan (STAR). BMC Musculoskelet Disord. 2021 Sep 8;22(1):765. doi: 10.1186/s12891-021-04645-3.

Reference Type DERIVED
PMID: 34496821 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021SL029

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fusion Status After ACDF
NCT05986006 UNKNOWN NA
Allogeinic Bone Paste
NCT04605120 UNKNOWN NA